A clinical trial conducted in a neonatal intensive care unit has identified a new treatment protocol to improve lung growth and function among preterm infants.

The CPS-Ped may be an efficient outcome metric for monitoring disease severity and clinical improvement over time among infants with RSV-related critical illness.